309 related articles for article (PubMed ID: 15849486)
21. Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum.
Hedström J; Leinonen J; Sainio V; Stenman UH
Clin Chem; 1994 Sep; 40(9):1761-5. PubMed ID: 7520847
[TBL] [Abstract][Full Text] [Related]
22. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla.
Xu LH; Qian JB; Gu LG; Qiu JW; Ge ZM; Lu F; Wang YM; Li YM; Lu HS
J Gastroenterol Hepatol; 2011 Jul; 26(7):1139-44. PubMed ID: 21392105
[TBL] [Abstract][Full Text] [Related]
23. Serum Serine Peptidase Inhibitor Kazal-Type 1, Trypsinogens 1 to 3, and Complex of Trypsin 2 and α1-Antitrypsin in the Diagnosis of Severe Acute Pancreatitis.
Rainio M; Lindström O; Penttilä A; Itkonen O; Kemppainen E; Stenman UH; Kylänpää L
Pancreas; 2019 Mar; 48(3):374-380. PubMed ID: 30747826
[TBL] [Abstract][Full Text] [Related]
24. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
25. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of acute pancreatitis.
Kemppainen E; Puolakkainen P; Leppäniemi A; Hietaranta A; Grönroos J; Haapiainen R
Ann Chir Gynaecol; 1998; 87(3):191-4. PubMed ID: 9825062
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
[TBL] [Abstract][Full Text] [Related]
28. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
Pezzilli R; Gabbrielli A; Labate AM; D'Alessio P; Barakat B; Costamagna G; Dibenedetti F; Massa M; Merlini G; d'Eril GM
Hepatogastroenterology; 2003; 50(51):851-5. PubMed ID: 12828103
[TBL] [Abstract][Full Text] [Related]
29. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
[TBL] [Abstract][Full Text] [Related]
30. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
[TBL] [Abstract][Full Text] [Related]
31. Enzyme leakage, trypsinogen activation, and inflammatory response in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
Petersson U; Borgström A; Ohlsson K; Fork FT; Toth E
Pancreas; 2002 May; 24(4):321-8. PubMed ID: 11961483
[TBL] [Abstract][Full Text] [Related]
32. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
[TBL] [Abstract][Full Text] [Related]
33. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis.
Itkonen O; Koivunen E; Hurme M; Alfthan H; Schröder T; Stenman UH
J Lab Clin Med; 1990 Jun; 115(6):712-8. PubMed ID: 2366031
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis.
Kemppainen E; Hietaranta A; Puolakkainen P; Sainio V; Halttunen J; Haapiainen R; Kivilaakso E; Nevalainen T
Pancreas; 1999 Jan; 18(1):21-7. PubMed ID: 9888656
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the consensus and clinical definitions of pancreatitis with a proposal to redefine post-endoscopic retrograde cholangiopancreatography pancreatitis.
Artifon EL; Chu A; Freeman M; Sakai P; Usmani A; Kumar A
Pancreas; 2010 May; 39(4):530-5. PubMed ID: 20093992
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
[TBL] [Abstract][Full Text] [Related]
37. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.
Hackert T; Werner J; Gebhard MM; Klar E
Surgery; 2004 Feb; 135(2):131-8. PubMed ID: 14739847
[TBL] [Abstract][Full Text] [Related]
38. Effects of medications on post-endoscopic retrograde cholangiopancreatography pancreatitis.
Li N; Tieng A; Novak S; Fernandes A; Jalal PK; Akerman M; Sideridis K; Bank S
Pancreatology; 2010; 10(2-3):238-42. PubMed ID: 20484961
[TBL] [Abstract][Full Text] [Related]
39. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
[TBL] [Abstract][Full Text] [Related]
40. Using the 4-hour Post-ERCP amylase level to predict post-ERCP pancreatitis.
Sutton VR; Hong MK; Thomas PR
JOP; 2011 Jul; 12(4):372-6. PubMed ID: 21737899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
